Portugal's Hospital Surgery Freeze: 264,000 Waiting for Care in 2026

Portugal's National Health Service has been instructed to cap surgical and consultation activity for 2026, a directive that could force hundreds of thousands of residents to wait longer for critical care—including cancer operations—despite already swelling waiting lists.

Why This Matters

• 264,000 people already await surgery as of late 2025, a 3.4% increase from the prior year—and that queue may now grow further.

• Cancer surgery waiting lists climbed 4.7% in the first half of 2025; 577 oncology patients currently exceed the guaranteed maximum waiting time.

• Hospitals have been told: no production increase in 2026, a 10% cut in external procurement (medicines, clinical supplies, outsourced staff), and "zero new hires."

The Directive: Cost Control at the Expense of Care?

The Portugal National Health Service Executive Directorate, led by Álvaro Almeida since January 2025, issued the orders in October and reinforced them again in March 2026. Hospital administrators received clear instructions: do not expand outpatient consultations or surgical output beyond 2025 levels, and trim 10% from spending on external vendors—covering everything from pharmaceuticals to contract surgeons.

The rationale, according to the Directorate, is fiscal. Personnel costs are set to rise 5% this year (roughly €370 M), driven by career progression and public-sector wage increases. Without offsetting savings elsewhere, the Executive Directorate warns that the system risks overrunning its budget. The implicit trade-off: freeze activity to absorb the personnel bill.

Hospital managers, however, have publicly voiced alarm. Several told local media they fear the directive could endanger lives, particularly for patients with time-sensitive conditions such as cancer. One administrator, speaking anonymously to the press, noted that delaying treatment often worsens clinical outcomes and ultimately drives up costs when patients return in more advanced stages of disease.

The Political Flashpoint

On Saturday, Socialist Party leader José Luís Carneiro demanded the Portugal Ministry of Health and Prime Minister provide a full public explanation. Speaking to party supporters in Aveiro, Carneiro described the orders as a stealth cut that contradicts the government's public commitments.

"The Minister and the Prime Minister must explain publicly what instructions were given to reduce investment—and, in this case, the number of surgeries performed in the SNS," Carneiro said. He warned that the measure risks compounding an already grave backlog, citing recent data showing more than one million people waiting for a first specialist consultation and over a quarter-million queued for surgery at the end of 2025.

The government's official position stands in contrast to the internal directive. The Portugal Ministry of Health has repeatedly stated that the 2026 State Budget allocates funds for an increase in consultations and procedures, emphasizing efficiency and waste reduction rather than rationing. Prime Minister Luís Montenegro, in recent statements, rejected the characterization of cuts, insisting the focus is on "resource optimization" and smarter spending.

What This Means for Residents

For those already in the system—or about to enter it—the practical impact is straightforward: longer waits. The most recent snapshot, taken at year-end 2025, recorded approximately 264,000 people awaiting surgery and over one million awaiting a specialist appointment. Nearly 23,600 surgical patients had already breached the Guaranteed Maximum Response Time (TMRG), a 31% jump from 2024. Of these, 577 were oncology cases.

Cancer surgery queues grew 4.7% in the first six months of 2025 compared to the same period in 2024, even as public hospitals performed 6.9% more oncology operations—a sign that demand is outpacing capacity. The "zero production growth" order means hospitals cannot ramp up activity to clear the backlog, leaving patients in limbo.

The "zero new hires" rule compounds the problem. With staff turnover and retirements ongoing, hospitals face shrinking teams and rising burnout among existing clinicians. Surgical capacity depends not only on operating theaters but on anesthesiologists, nurses, and recovery staff—all constrained by the hiring freeze.

A New IT System Against an Old Problem

On a parallel track, Portugal has just promulgated Decree-Law 12/2026, which creates the National System for Managing Access to Consultations and Surgery (SINACC). The platform, set to go live on August 1, replaces the aging SIGIC database and promises centralized tracking, artificial intelligence alerts for critical cases, and real-time enforcement of maximum waiting times.

President Marcelo Rebelo de Sousa signed the law but attached formal reservations. He questioned why surgical access is being addressed before consultation access (since patients typically need a specialist appointment to be listed for surgery) and flagged gaps in regulation around workforce integration and patient data protection.

The new system may improve visibility and accountability, but it cannot conjure additional operating rooms or surgeons. Observers note that a more transparent queue does little to help patients if the queue itself is frozen by budget directives.

How Europe Handles Budget Pressure Without Rationing

Other European countries facing fiscal constraints have adopted a mix of strategies to maintain surgical throughput. Denmark, the Netherlands, and Italy consistently report the shortest elective surgery wait times on the continent, thanks to clinical prioritization tools that triage patients by medical urgency rather than chronological order. New Zealand's model, which combines triage software with targeted capacity increases, has become a case study in balancing cost control and patient flow.

Centralized procurement of biosimilars, generic drugs, and medical devices is another common lever, allowing systems to cut unit costs without cutting procedures. Some jurisdictions have also experimented with public-private partnerships—Madrid's hybrid-management hospitals, for example, report significantly shorter surgical waits than fully public facilities in the same region.

Prevention and upstream intervention are widely recognized as the most durable cost-containment strategies, yet Portugal saw a 10.3% decline in breast cancer screening in 2025, even as colorectal and cervical screening edged up slightly. Catching disease early typically reduces the need for complex, expensive surgery later—a dynamic the current directive appears to ignore.

The Broader Picture: A System Under Strain

Portugal's health system entered 2026 already stretched. Despite a modest 1.2% increase in surgical volume in 2025 (roughly 884,000 operations), some sources reported a 0.7% decline in total procedures—the first drop since the pandemic. Waiting lists grew faster than capacity, a gap the "no-growth" directive will widen.

Public health analysts warn that deferring care often proves a false economy. Patients whose conditions deteriorate while waiting require more intensive—and expensive—interventions down the line. Emergency admissions also tend to be costlier and less efficient than scheduled elective surgery.

The Executive Directorate, led by Álvaro Almeida, has defended its management approach. In interviews earlier this year, Almeida insisted the SNS is responding better than in the past and attributed visible strains—such as emergency department crowding during flu season—to demand spikes rather than systemic shortfalls. He disputed reports of equipment shortages, arguing that longer wait times reflect transient peaks rather than chronic under-resourcing.

What Happens Next

The political debate is unlikely to cool soon. The Socialist Party, which governed until mid-2024, has seized on the directive as evidence of broken promises, while the current center-right administration insists its budget figures tell a different story. Reconciling internal cost-containment memos with public commitments to expand access will require either additional funding, productivity gains that outstrip the hiring freeze, or a candid recalibration of public expectations.

For residents navigating the system, the advice remains unchanged: register early, keep documentation current, and be prepared for delays. The SINACC platform, once operational in August, should at least make waiting times and referral status more transparent. Until then, the gap between need and capacity—already measured in hundreds of thousands of people—looks set to grow wider, not narrower, through the rest of 2026.